US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 3.150
  • -0.150-4.55%
Close Apr 25 16:00 ET
  • 3.130
  • -0.020-0.63%
Post 16:06 ET
132.87MMarket Cap-1412P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
40,383.81%112.55M
143.37%679K
145.78%408K
Operating revenue
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
40,383.81%112.55M
143.37%679K
145.78%408K
Cost of revenue
Gross profit
Operating expense
10.37%167.36M
16.08%43.91M
3.66%40.58M
7.85%42.51M
14.54%40.36M
30.42%151.63M
6.23%37.83M
22.50%39.15M
46.27%39.41M
62.04%35.24M
Selling and administrative expenses
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
19.83%7.9M
17.76%7.94M
67.63%8.78M
-General and administrative expense
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
19.83%7.9M
17.76%7.94M
67.63%8.78M
Research and development costs
12.20%133.59M
17.98%35.27M
4.70%32.71M
7.35%33.79M
20.30%31.83M
32.23%119.07M
6.86%29.89M
23.19%31.24M
55.78%31.48M
60.26%26.46M
Operating profit
-487.11%-116.22M
-57.23%-30.87M
-152.34%-38.42M
68.35%-12.26M
0.42%-34.68M
81.78%-19.8M
31.68%-19.63M
331.70%73.4M
-45.25%-38.73M
-61.39%-34.83M
Net non-operating interest income expense
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
3,724.53%2.03M
1,331.58%544K
101.56%129K
Non-operating interest income
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
3,724.53%2.03M
1,331.58%544K
101.56%129K
Other net income (expense)
-209.06%-289K
-211.27%-79K
-180.90%-72K
-151.54%-67K
-184.00%-71K
243.24%265K
198.61%71K
242.31%89K
228.71%130K
34.21%-25K
Gain on sale of security
-155.19%-170K
-156.90%-33K
-131.75%-40K
-129.08%-41K
-229.41%-56K
313.89%308K
211.54%58K
281.82%126K
250.00%141K
45.16%-17K
Other non- operating income (expenses)
-176.74%-119K
-453.85%-46K
13.51%-32K
-136.36%-26K
-87.50%-15K
-4.88%-43K
165.00%13K
-428.57%-37K
-57.14%-11K
-14.29%-8K
Income before tax
-642.29%-103.18M
-67.41%-27.84M
-146.58%-35.18M
76.78%-8.84M
9.79%-31.33M
87.20%-13.9M
42.06%-16.63M
338.97%75.52M
-42.39%-38.06M
-61.11%-34.73M
Income tax
-161.95%-9.38M
-98.74%190K
-30,283.33%-16.3M
9,324.24%3.11M
11,200.00%3.62M
1,002.68%15.15M
3,747.57%15.03M
107.63%54K
107.84%33K
123.36%32K
Net income
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
-62.29%-34.76M
Net income continuous Operations
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
-62.29%-34.76M
Minority interest income
Net income attributable to the parent company
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
-62.29%-34.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
-62.29%-34.76M
Basic earnings per share
-223.19%-2.23
10.67%-0.67
-125.00%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
316.87%1.8
-28.17%-0.91
-43.10%-0.83
Diluted earnings per share
-223.19%-2.23
10.67%-0.67
-126.32%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
306.02%1.71
-28.17%-0.91
-43.10%-0.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M40,383.81%112.55M143.37%679K145.78%408K
Operating revenue -61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M40,383.81%112.55M143.37%679K145.78%408K
Cost of revenue
Gross profit
Operating expense 10.37%167.36M16.08%43.91M3.66%40.58M7.85%42.51M14.54%40.36M30.42%151.63M6.23%37.83M22.50%39.15M46.27%39.41M62.04%35.24M
Selling and administrative expenses 3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M19.83%7.9M17.76%7.94M67.63%8.78M
-General and administrative expense 3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M19.83%7.9M17.76%7.94M67.63%8.78M
Research and development costs 12.20%133.59M17.98%35.27M4.70%32.71M7.35%33.79M20.30%31.83M32.23%119.07M6.86%29.89M23.19%31.24M55.78%31.48M60.26%26.46M
Operating profit -487.11%-116.22M-57.23%-30.87M-152.34%-38.42M68.35%-12.26M0.42%-34.68M81.78%-19.8M31.68%-19.63M331.70%73.4M-45.25%-38.73M-61.39%-34.83M
Net non-operating interest income expense 136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M3,724.53%2.03M1,331.58%544K101.56%129K
Non-operating interest income 136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M3,724.53%2.03M1,331.58%544K101.56%129K
Other net income (expense) -209.06%-289K-211.27%-79K-180.90%-72K-151.54%-67K-184.00%-71K243.24%265K198.61%71K242.31%89K228.71%130K34.21%-25K
Gain on sale of security -155.19%-170K-156.90%-33K-131.75%-40K-129.08%-41K-229.41%-56K313.89%308K211.54%58K281.82%126K250.00%141K45.16%-17K
Other non- operating income (expenses) -176.74%-119K-453.85%-46K13.51%-32K-136.36%-26K-87.50%-15K-4.88%-43K165.00%13K-428.57%-37K-57.14%-11K-14.29%-8K
Income before tax -642.29%-103.18M-67.41%-27.84M-146.58%-35.18M76.78%-8.84M9.79%-31.33M87.20%-13.9M42.06%-16.63M338.97%75.52M-42.39%-38.06M-61.11%-34.73M
Income tax -161.95%-9.38M-98.74%190K-30,283.33%-16.3M9,324.24%3.11M11,200.00%3.62M1,002.68%15.15M3,747.57%15.03M107.63%54K107.84%33K123.36%32K
Net income -222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M-62.29%-34.76M
Net income continuous Operations -222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M-62.29%-34.76M
Minority interest income
Net income attributable to the parent company -222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M-62.29%-34.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M-62.29%-34.76M
Basic earnings per share -223.19%-2.2310.67%-0.67-125.00%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75316.87%1.8-28.17%-0.91-43.10%-0.83
Diluted earnings per share -223.19%-2.2310.67%-0.67-126.32%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75306.02%1.71-28.17%-0.91-43.10%-0.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg